Cardiometabolic syndrome – new approaches
Noteworthy sessions at this year’s SA Heart Conference focused on exploring whether there is a united front among the three specialist groups that care for patients with cardiorenal metabolic syndrome
You will learn:
- How different specialists attending to the heart, kidneys and diabetes are developing unified approaches with newer agents that protect target organs in patients with and without diabetes
- To view the role of SGLT-2 inhibitors in the treatment of patients with heart failure across all LVEF categories
- To adapt treatment of diabetic patients to suit the individual patient’s risk profile and to use protective agents earlier, even at the time of first diagnosis
To access this module, please register or login: